Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2021-04-26
Target enrollment:
Participant gender:
Summary
A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the
Pharmacodynamics, Relative Bioavailability, and Safety of Three Doses of Tiotropium Bromide
Inhalation Solution in Subjects with Chronic Obstructive Pulmonary Disease